CanFinis Therapeutics is a Kolkata-based start-up in Life Sciences founded by entrepreneurs, key leaders, and practicing clinicians. CanFinis is developing novel CAR-T products specifically for solid tumor indications predominant in Southeast Asia. CanFinis has an in-licensed novel CAR-T for clinical development and commercialization in India and South-East Asia. Based on a detailed understanding of patient tumor antigens CanFinis optimizes treatment and saves crucial time and expenses while developing novel CAR-Ts. CanFinis brings relevant talent and technologies from all over the world and has an impact on treating patients as well as in creating a huge market for personalized cancer therapeutics.